rfi. Thx for your comment ...and thx for your work on VKTX , which I still own . Have you read this re OMER 's Narsoplimab ? https://pubmed.ncbi.nlm.nih.gov/33163724/
Conclusion: This interim analysis suggests that narsoplimab treatment is safe, is well tolerated, and may result in clinically meaningful reductions in proteinuria and stability of eGFR in high-risk patients with advanced IgAN
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.